Table 3.
Representative commercially available technologies available to diagnose the leading causes of maternal mortality. Notably, many of the listed technologies are lacking robust usability, scalability, and field performance studies.
Condition | Representative Technology | Analyte Measured | Core Technology | Input Sample | Diagnostic Performance | Cost | Power* | Health System Use Level | Advantages | Limitations | Image |
---|---|---|---|---|---|---|---|---|---|---|---|
HIV Diagnosis | Alere Determine HIV-1/2 Ag/Ab Combo376,377 | HIV-1/2 antibodies and free HIV-1 p24 antigen | Lateral Flow | Whole Blood | Sensitivity: 99.9% Specificity: 98.3%–99.9% †376 |
$18.22 | None | Heatlh Post | Results in 20 minutes; approved for fingerstick use; excellent sensitivity | Unsuitable for acute infection and treatment monitoring |
![]() |
HIV Monitoring | Xpert HIV-1 Viral Load24,378,379 | HIV RNA | Automated MicrobiologyAnalyzer | Whole Blood | R2=0.92; limit of detection 40 cp/mL †**378 | $17,000 instrument $9.98/test | Mod | Reference Lab | Minimal hands-on time; 92-minute run time; high throughput; integrated sample preparation | High cost |
![]() |
Malaria | SD BIOLINE Malaria Ag Pf60,380,381 | Plasmodium falciparum histidine-rich protein II (PfHRP-II) | Lateral Flow | Whole Blood | Sensitivity: 95% Specificity: 97.1% † 60 |
$0.70 | None | Health Post | Low-cost; minimal training requirements; results in 30 minutes; excellect sensitivity | Counterfeit tests on market; limit-of-detection unsuitable for submicroscopic infections |
![]() |
Diabetes | LifeScan OneTouch Ultra 298,382 | Glucose | Lateral Flow with Reader | Whole Blood | AUC: 0.778 95% CI: 0.726–0.829 † 97 | $19.99 instrument $1.45–1.60/test | Low | Health Post | Widely available; integrated sample processing | High per-test cost |
![]() |
Anemia | HemoCue383–385 | Hemoglobin | Microfluidics | Whole Blood | R2=0.85–0.995 AUC: 0.96† 383 |
$449 instrument $1.53–$1.86/test | Low | Health Post | Integrated sample processing | High per-test cost |
![]() |
Hemorrhage | BRASS-V drape146,148,386 | Blood Loss | Blood Collection and Volume Measurement | Whole Blood | R=0.928 †† 148 | $4/test | None | Health Post | Accurate; minimal training requirements | High per-test cost |
![]() |
Pre-eclampsia | Alere Triage PlGF185,186,387 | Placental Growth Factor | Lateral Flow with Reader | Plasma | Sensitivity: 77% Specificity: 95% † 186 | $1750 instrument $50/test |
Mod | Health Center | Results in 20 minutes | High per test cost; requires plasma separation from whole blood |
![]() |
Bacterial Infection | Blood Culture388–391 | Bacterial Load | Laboratory Microbiology | Sterile Whole Blood | Sensitivity: 73% † 388 | $28 | High | Reference Lab | Prone to contamination and false positives |
![]() |
|
PROM | Amnisure ROM205,219,392 | Placental alpha-microglobulin 1 (PAMG-1) | Lateral Flow | Vaginal Swab | Sensitivity: 96.8% Specificity: 98.3% † 205 |
$60/test | None | Health Center | Excellent sensitivity, minimal training requirements, results in 10 minutes | High per test cost, blood contamination can give false positives |
![]() |
Power can be battery based, with low indicating small, easily replaceable batteries, moderate indicating larger, more expensive batteries, and high indicating dependency on electrical power grid.
Reported diagnostic performance is idenpendently verified.
Diagnostic performance is manufacturer reported.
Reported diagnostic performance was achieved using plasma samples.
HIV Diagnosis image provided courtesy Alere Inc.
HIV Monitoring image provided courtesy of Cepheid.
Malaria image provided courtesy Alere Inc.
Hemorrhage image reproduced from Reference 386 under the terms of Creative Commons Attribution License.
Pre-eclampsia image provided courtesy Alere Inc.
Bacterial Infection image reproduced from Reference 391 under the terms of Creative Commons Attribution License.
PROM image provided courtesy of Qiagen.